Table 2 from Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit

Key Points

• The analysis shows how drug interactions affect treatment outcomes in patients with solid tumors, improving patient management.
• Patients undergoing immunotherapy for solid tumors had varied responses based on identified drug interactions.
• Using a drug interaction framework, the research draws upon data collected in a Phase I unit for improved outcomes in treatment.
• The findings may inform future immunotherapy strategies, enabling better tailored treatments for solid tumor patients.